CA1017675A - Traitement de la maladie de parkinson par la l-propyle l-leucyle glycine amide - Google Patents

Traitement de la maladie de parkinson par la l-propyle l-leucyle glycine amide

Info

Publication number: CA1017675A
Authority: CA; Canada
Prior art keywords: prolyl; disease; treat parkinson; glycine amide; leucyl glycine
Prior art date: 1972-12-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA166,764A

Other languages

English (en)

Other versions

CA166764S (en

Inventor

Nicholas P. Plotnikoff

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Abbott Laboratories

Original Assignee

Abbott Laboratories

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1972-12-26

Filing date

1973-03-22

Publication date

1977-09-20

1973-03-22 Application filed by Abbott Laboratories filed Critical Abbott Laboratories

1977-09-20 Application granted granted Critical

1977-09-20 Publication of CA1017675A publication Critical patent/CA1017675A/fr

Status Expired legal-status Critical Current

Links

FXGIMYRVJJEIIM-UHFFFAOYSA-N 2-[[4-methyl-2-(pyrrolidin-1-ium-2-carbonylamino)pentanoyl]amino]acetate Chemical compound OC(=O)CNC(=O)C(CC(C)C)NC(=O)C1CCCN1 FXGIMYRVJJEIIM-UHFFFAOYSA-N 0.000 title 1
208000018737 Parkinson disease Diseases 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
- C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

CA166,764A 1972-12-26 1973-03-22 Traitement de la maladie de parkinson par la l-propyle l-leucyle glycine amide Expired CA1017675A (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US31814272A	1972-12-26	1972-12-26

Publications (1)

Publication Number	Publication Date
CA1017675A true CA1017675A (fr)	1977-09-20

Family

ID=23236838

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA166,764A Expired CA1017675A (fr)	1972-12-26	1973-03-22	Traitement de la maladie de parkinson par la l-propyle l-leucyle glycine amide

Country Status (2)

Country	Link
US (1)	US3795738A (fr)
CA (1)	CA1017675A (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3931184A (en) *	1974-10-31	1976-01-06	Abbott Laboratories	Purification method for prolyl-leucylglycinamide
DE3226241A1 (de) *	1982-07-14	1984-01-26	Basf Ag, 6700 Ludwigshafen	N-acylderivate von peptiden, ihre herstellung und verwendung bei der bekaempfung von krankheiten und mittel dafuer
US5767083A (en) *	1994-05-04	1998-06-16	Innapharma, Inc.	Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent
US5589460A (en) *	1994-05-04	1996-12-31	Innapharma, Inc.	Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent
US6767897B2 (en) *	1994-05-04	2004-07-27	Innapharma, Inc.	Therapeutic uses of tri-, tetra-, penta-, and polypeptides
US5859031A (en)	1995-06-07	1999-01-12	Gpi Nil Holdings, Inc.	Small molecule inhibitors of rotamase enzyme activity
IL154318A (en)	2003-02-06	2010-05-31	Sarah Herzog Memorial Hospital	Pharmaceutical compositions for the treatment of movement disorders
AU2008303955A1 (en) *	2007-09-11	2009-04-02	Mondobiotech Laboratories Ag	Use of melanocyte-stimulating hormone release-inhibiting factor as a therapeutic agent in the treatment of Pseudomonas aeruginosa infection
WO2009043478A2 (fr) *	2007-09-11	2009-04-09	Mondobiotech Laboratories Ag	Utilisation d'un peptide en tant qu'agent thérapeutique

1972
- 1972-12-26 US US00318142A patent/US3795738A/en not_active Expired - Lifetime
1973
- 1973-03-22 CA CA166,764A patent/CA1017675A/fr not_active Expired

Also Published As

Publication number	Publication date
US3795738A (en)	1974-03-05

Similar Documents

Publication	Publication Date	Title
BR7202331D0 (pt)	1973-05-24	Conjunto de eletrodo implantavel no tecido do corpo
CA987391A (en)	1976-04-13	Therapeutic bioelectric growth stimulator
BR7307049D0 (pt)	1974-07-18	Composicao de materia estimulante dos detectores de frio do corpo humano
FR2283590A1 (fr)	1976-03-26	Procede de stimulation nerveuse et stimulateur d'application du procede
NL188078C (nl)	1992-04-01	Farmaceutisch preparaat voor de behandeling van hartarrhytmieen en myocardiale aandoeningen.
AU501501B2 (en)	1979-06-21	Tissue stimulation unit
FR2282259A1 (fr)	1976-03-19	Medicament sous forme de grains friables
BE816683A (fr)	1974-12-23	Masseur therapeutique corporel
FR2299853A1 (fr)	1976-09-03	Bandage therapeutique pour l'administration de scopolamine par voie percutanee
ZA72423B (en)	1972-10-25	Improvements in or relating to the treatment of diseases of the skin or mucosa
PH14013A (en)	1980-12-08	Manufactured products for topical application to or consumption by the human body containing an ingredient capable of stimulating the cold receptors of the nervous system
ZA772514B (en)	1978-04-26	Improvements relating to the administration of pharmaceutically active substances to animals
FR2303535A1 (fr)	1976-10-08	Peptides de l-3-(3,4-dihydroxyphenyl) 2-methylalanine et leur procede de preparation
BE823986A (fr)	1975-06-30	Amino-acides cylciques et sel de ces acides
PH13628A (en)	1980-08-14	Manufactured products for topical application to or consumption by the human body containing an ingredient capable of stimulating the gold receptors of the nervous system
IL49285A0 (en)	1976-05-31	The preparation of 2'-(6-alkoxycarbonylhexyl)-2-cyclopenten-1-one
CA1008370A (en)	1977-04-12	Product for the treatment of keratinous tissues
PH10473A (en)	1977-05-11	Use of l-propyl l-leucyl glycine amide to treat parkinson's disease
AU6145873A (en)	1975-04-17	Treatment of parkinson@s disease
JPS56108771A (en)	1981-08-28	Benzimidazoline salt and application to agricultural drug
CA1019740A (fr)	1977-10-25	Derives de l'amino propanediol, leur procede de preparation et leurs applications en therapeutique humaine
IT7235774U1 (it)	1973-11-16	Dispositivo per l'applicazione diretta di sostanze medicinali nelle cavita' corporee ad esempio l'utero
JPS51142885A (en)	1976-12-08	Living body transducer
CA964582A (en)	1975-03-18	Combination of l-dopa and 2-imino-5-phenyl-4-oxazolidinone used to treat parkinson's disease
CA989731A (en)	1976-05-25	Treatment of heart diseases